BillionToOne Reports Q2 2026 Revenue of $109.4M
The company reported a 64% increase in Q2 revenue, driven by growth in both prenatal and oncology testing. Management reiterated full-year guidance for $450M to $465M in revenue.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day